| Ronnie Morris |
Ronnie Morris is the founder of MDVIP LLC (Florida), which was founded in 2000. He held the title of Director & Medical Director at MDVIP LLC. Dr. Morris is currently the Chief Executive Officer & Director at Champions Oncology, Inc., a position he has held since 2010. In the past, Dr. Morris served as the Chief Medical Officer & Executive Vice President at Alliance Care, Inc. from 2004 to 2006. Prior to that, he was the Managing Partner at ProHealth Medical, Inc. from 1996 to 2004. Dr. Morris obtained his doctorate degree from the University of Medicine & Dentistry of New Jersey in 1993. |
| David Sidransky |
David Sidransky is the founder of Champions Oncology, Inc. (founded in 2008) and Israel Biotech Fund (founded in 2014). He is currently the Lead Director at Champions Oncology, Inc. and the General Partner at Israel Biotech Fund. Dr. Sidransky's current jobs include being the Chairman at Old Ayala, Inc. (since 2019), Biosight Therapeutics, Inc. (since 2013), Ayala Pharmaceuticals, Inc. (since 2017), Rosetta Genomics Ltd. (since 2009), Orgenesis, Inc. (since 2013), The Sidney Kimmel Comprehensive Cancer Center (since 1994), Immune Pharmaceuticals, Inc., Galmed Pharmaceuticals Ltd. (since 2014), Ascentage Pharma Group International Co., Ltd. (since 2021), Biond Biologics Ltd., Cactus Acquisition Corp. 1 Ltd., Exoprother Medical, The Johns Hopkins University (since 1998), American Society of Clinical Oncology, Inc., Biomerk, Inc., The Johns Hopkins University School of Medicine (since 1994), and The American Association of Cancer Research. Dr. Sidransky's former jobs include being the Chairman at Tamir Biotechnology, Inc. (2007-2020), Vice Chairman at ImClone LLC (2004-2008), Chairman at Old Ayala, Inc. (2017-2023), Independent Director at AMAG Pharma USA, Inc. (2012-2013), Director at AMAG Pharma USA, Inc. (2010-2012), Director at Zila, Inc. (2006-2007), Board of Director at Celsus Therapeutics Plc (2012-2015), Director at Advaxis, Inc. (2013-2015), Director at American Association for Cancer Research (2005-2008), Director at National Institute of Dental & Craniofacial Research, Director at Efranat Ltd., Director at Akari Therapeutics Plc, Director at Cardiff Oncology, Inc., and Senior Editor at Clinical Cancer Research (2005-2008). Dr. Sidransky's education includes an undergraduate degree from Brandeis University (1981) and a doctorate degree from Baylor College of Medicine. |
| Karin Abarca Heidemann |
Karin Abarca Heidemann is currently the Executive Vice President-Scientific Operations at Champions Oncology, Inc. Previously, she worked as the Vice President-Scientific Operations at Rockland Immunochemicals, Inc. from 2011 to 2019. She completed her undergraduate degree at Universität zu Köln. |
| Michael Ritchie |
Michael Ritchie is currently the Chief Commercial Officer at Champions Oncology, Inc. He holds an MBA from New York University and a doctorate from Temple University School of Medicine. |
| Maria Mancini |
Maria Mancini is currently the Chief Operating Officer at Champions Oncology, Inc. She previously worked as the Research Director at Biomodels LLC from 2011 to 2015. Dr. Mancini holds a doctorate degree from the University of Maine. |
| David Barry Miller |
David Barry Miller's current job is Chief Financial Officer at Champions Oncology, Inc. Formerly, Mr. Miller worked as Vice President-Finance & Operations at IDT Corp. from 2000 to 2005. He also served as Assistant VP-Internal Audit Department at Deutsche Bank Securities, Inc. from 1997 to 1999. Additionally, he worked as a Senior Accountant at Margolin, Winer & Evans LLP. Mr. Miller was Vice President-Finance & Operations at Distribution Management Consolidators Worldwide LLC from 2010 to 2013. Prior to that, he held the position of Chief Financial Officer at NAF Funding LLC from 2006 to 2010. He also worked as a Senior Accountant at Schonbraun, Safris, Sternlieb & Co. Llc. In terms of education, Mr. Miller obtained an MBA from Fordham University in 1999. He completed his undergraduate studies at Yeshiva University in 1991. |
| Joel Ackerman |
Joel Ackerman's current jobs include being the Chairman at Champions Oncology, Inc. since 2017, Chairman-Governing Board at One Acre Fund since 2009, Chief Financial Officer & Treasurer at DaVita, Inc. since 2019, and Trustee at The Huntington At Nashua since 2016. His former jobs include being a Managing Director at Warburg Pincus LLC from 1993 to 2008, an Independent Director at Coventry Health Care, Inc. from 2011 to 2013, an Independent Director at Kindred Healthcare LLC from 2011 to 2018, a Director at HNI HoldCo, Inc. from 2001 to 2009, a Director at Medical Staffing Network, Inc. in 2005, a Director at Spheris, Inc. from 2004 to 2008, and a General Partner at Warburg Pincus & Company US LLC in 2005. Mr. Ackerman's education includes an undergraduate degree from The Trustees of Columbia University in The City of New York in 1988 and a graduate degree from Harvard University in 1990. |
| Brady Davis |
Brady Davis currently works at Champions Oncology, Inc., as President from 2023. |
| Daniel N. Mendelson |
Daniel N. Mendelson was the founder of Avalere Health LLC, founded in 2000, where he held the title of President & Chief Executive Officer. He is also the founder of Guidon Partners LP. Currently, he is the Chief Executive Officer-Morgan Health at JPMorgan Chase & Co. and an Operating Partner at Welsh, Carson, Anderson & Stowe since 2019. He is also a Director at Centrexion Therapeutics Corp. since 2018, an Independent Director at Champions Oncology, Inc. since 2013, a Director at Vera Whole Health, Inc., and a Director at Alliance For Health Policy, Inc. He previously served as an Independent Director at Coventry Health Care, Inc. from 2005 to 2013, an Independent Director at HMS Holdings Corp. from 2013 to 2015, and an Independent Director at PharMerica Corp. from 2007 to 2017. He also held the title of Associate Director-Health at the US Office of Management & Budget from 1998 to 2000. He received his undergraduate degree from Oberlin College and his graduate degree from Harvard Kennedy School of Government. |
| Scott Russell Tobin |
Scott Russell Tobin is currently a Director at Cortera, Inc., Credifi Corp., Diablo Technologies, Inc., Champions Oncology, Inc., Cross River Bank, Inc., Zerto Ltd., Cumulus Networks, Inc., Zerto, Inc., GuardiCore Ltd., Hi Bob Ltd., Code Ocean, Inc., Sofar Sounds Ltd., UBQ Materials Ltd., Xsight Labs Ltd., Battery Ventures, and Battery Ventures (Israel). He previously worked as a Director at Ruckus Network, Inc., The Tennis Channel, Inc., Cyren Call Communications Corp., Future Vision, Inc., More Magic Solutions, Inc., Pursway Ltd., ActivePath, Inc., StratoScale Ltd., Battery Partners IX, LLC, and First Albany Corp. Mr. Tobin obtained his undergraduate degree from Brandeis University in 1992. |
| Robert Brainin |
Robert Brainin is currently the Chief Executive Officer at Fjord Holding LLC and the Chief Executive Officer at Wuxi NextCode Genomics USA, Inc. He is also the Director at Children's Tumor Foundation, the Independent Director at Champions Oncology, Inc., and the Chief Business Officer & Executive Vice President at Veracyte, Inc. Previously, he served as the Chief Executive Officer & Director at Genuity Science, Inc., the Vice President & General Manager-Life Sciences at Illumina, Inc., and the Vice President-Enterprise Genomics Solutions at Thermo Fisher Scientific, Inc. Mr. Brainin completed his undergraduate degree at Emory University and his graduate degree at Harvard Law School. |
| Philip Breitfeld |
Philip Breitfeld is the founder of The Breitfeld Group, LLC, which is founded in 2016, where he is currently the Managing Director. He is also currently an Independent Director at Champions Oncology, Inc. since 2016 and the Chief Medical Officer at Allterum Therapeutics, Inc. since 2020. Dr. Breitfeld's former positions include Vice President at IQVIA, Inc., Global Vice President at Quintiles, Inc. (California) from 2011 to 2015, and Associate Chief Medical Officer at BioCrystal Ltd. from 2007 to 2009. Dr. Breitfeld holds a doctorate from the University of Rochester and an undergraduate degree from Princeton University. |
